Aranding, Arjay .
HRN: 26-38-23 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/16/2024
12/22/2024
IV
65mg
Q6
PCAP D
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes